Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jili Deng

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Oncology Reports|November 17, 2020
Germline mutations and blood malignancy (Review)Yuping Gong, Jili Deng, Xia Wu
Computational Intelligence and Neuroscience|June 23, 2022
Data Analysis for Modeling the Effect of Acupuncture on Postchemotherapy Cancer Fatigue in Gynecologic Oncology PatientsJili Deng, Yao Qian, Xingyu Chen, et al.
Diagnostic Pathology|December 12, 2023
Recognizing puzzling PD1 + infiltrates in marginal zone lymphoma by integrating clonal and mutational findings: pitfalls in both nodal and transformed splenic casesJili Deng, Youjun Cao, Xinting Diao, et al.
BMC Cancer|September 7, 2021
Comparison of monoclonal antibodies targeting CD38, SLAMF7 and PD-1/PD-L1 in combination with Bortezomib/Immunomodulators plus dexamethasone/prednisone for the treatment of multiple myeloma: an indirect-comparison Meta-analysis of randomised controlled trialsWu Ye, Xia Wu, Xiaoyan Liu, et al.
Annals of Hematology|March 23, 2026
Current evidence and strategies for bridging therapy in CD19-directed chimeric antigen receptor T-cell therapy for relapsed/refractory large B-cell lymphomasJie Lv, Yan Xie, Chen Zhang, et al.
Annals of Hematology|September 5, 2019
Prognostic significance of the EVI1 gene expression in patients with acute myeloid leukemia: a meta-analysisXia Wu, Huifang Wang, Jili Deng, et al.
Hematology (Amsterdam, Netherlands)|December 8, 2022
Clinical prognostic risk analysis and progression factor exploration of primary breast lymphomaJili Deng, Lan Mi, Xiaopei Wang, et al.
European Journal of Haematology|July 5, 2020
The prognostic impact of variant allele frequency (VAF) in TP53 mutant patients with MDS: A systematic review and meta-analysisJili Deng, Xia Wu, Yantao Ling, et al.
Journal of Cancer|January 3, 2024
Autologous stem cell transplant for refractory and relapsed peripheral T-cell lymphoma: a retrospective study in ChinaChen Zhang, Jie Lv, Jili Deng, et al.
BMJ Open|February 1, 2023
Prognostic significance of <i>KMT2A-</i>PTD in patients with acute myeloid leukaemia: a systematic review and meta-analysisWu Ye, Mingzhu Ma, Xia Wu, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Oncology Reports|November 17, 2020
Germline mutations and blood malignancy (Review)Yuping Gong, Jili Deng, Xia Wu
Computational Intelligence and Neuroscience|June 23, 2022
Data Analysis for Modeling the Effect of Acupuncture on Postchemotherapy Cancer Fatigue in Gynecologic Oncology PatientsJili Deng, Yao Qian, Xingyu Chen, et al.
Diagnostic Pathology|December 12, 2023
Recognizing puzzling PD1 + infiltrates in marginal zone lymphoma by integrating clonal and mutational findings: pitfalls in both nodal and transformed splenic casesJili Deng, Youjun Cao, Xinting Diao, et al.
BMC Cancer|September 7, 2021
Comparison of monoclonal antibodies targeting CD38, SLAMF7 and PD-1/PD-L1 in combination with Bortezomib/Immunomodulators plus dexamethasone/prednisone for the treatment of multiple myeloma: an indirect-comparison Meta-analysis of randomised controlled trialsWu Ye, Xia Wu, Xiaoyan Liu, et al.
Annals of Hematology|March 23, 2026
Current evidence and strategies for bridging therapy in CD19-directed chimeric antigen receptor T-cell therapy for relapsed/refractory large B-cell lymphomasJie Lv, Yan Xie, Chen Zhang, et al.
Annals of Hematology|September 5, 2019
Prognostic significance of the EVI1 gene expression in patients with acute myeloid leukemia: a meta-analysisXia Wu, Huifang Wang, Jili Deng, et al.
Hematology (Amsterdam, Netherlands)|December 8, 2022
Clinical prognostic risk analysis and progression factor exploration of primary breast lymphomaJili Deng, Lan Mi, Xiaopei Wang, et al.
European Journal of Haematology|July 5, 2020
The prognostic impact of variant allele frequency (VAF) in TP53 mutant patients with MDS: A systematic review and meta-analysisJili Deng, Xia Wu, Yantao Ling, et al.
Journal of Cancer|January 3, 2024
Autologous stem cell transplant for refractory and relapsed peripheral T-cell lymphoma: a retrospective study in ChinaChen Zhang, Jie Lv, Jili Deng, et al.
BMJ Open|February 1, 2023
Prognostic significance of <i>KMT2A-</i>PTD in patients with acute myeloid leukaemia: a systematic review and meta-analysisWu Ye, Mingzhu Ma, Xia Wu, et al.
Pageof 3